ClinicalTrials.Veeva

Menu

HIAS II - Study of Nutritional Supplementation in Hospitalized Children With Persistent Diarrhea or Malnutrition

University of Virginia logo

University of Virginia

Status and phase

Withdrawn
Phase 3

Conditions

Diarrhea, Malnutrition
Other Nutritional Deficiencies

Treatments

Drug: Glycine
Drug: Alanyl-glutamine

Study type

Interventional

Funder types

Other
NIH

Identifiers

Details and patient eligibility

About

This study will determine the effect of 7 days supplementation of alanyl-glutatime or glycine on the damaged intestinal barrier function on day 8 in children with persistent diarrhea or malnutrition.

Full description

The purpose of this study is to determine the effect of 7 days supplementation of alanyl-glutamine or glycine on the damaged intestinal barrier function, measured by lactulose/mannitol test on day 8, in children with persistent diarrhea or malnutrition; on diarrhea frequency and duration, weight gain, protein loss, intestinal inflammation, and lactoferrin excretion.

Sex

All

Ages

3 months to 3 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Children ages 3 to 36 months with a history of persistent diarrhea (3 or more unformed stools/day) for >2 weeks or height-for-age Z-score (HAZ) less than negative 1, which is the median of HAZ score in children at HIAS.
  2. Be an inpatient and willing to stay for 7 nights at HIAS.
  3. Child´s parent or guardian must sign informed consent..

Exclusion criteria

  1. Children exclusively breast-fed (Reason: The diet needs to be controlled in order to evaluate the study treatment effect)
  2. Children who participated in the community study or any other study within the past two years (Reason: The children in the community study will have received glutamine.)
  3. Children with suspected other illnesses as indicated by fever >102º F at time of screening off antipyretics
  4. Children with suspected systemic disease at the time of screening including but not limited to shock, meningitis, sepsis, pneumonia, tuberculosis, varicella
  5. Severe malnutrition defined as HAZ <-3 or WAZ <-3.5 or any child weighing <10 lbs. (4.5 kg) or any child with a weight-to-height ratio <60% of the NCHS age adjusted norm.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems